BRIEF: GenFleet shares double in heavily oversubscribed IPO
Shares of biopharmaceutical firm GenFleet Therapeutics (Shanghai) Inc. (2595.HK) opened up 116% in their Hong Kong trading debut on Friday, and held on to the gains to close up more…
Cancer drug maker Genfleet joins Hong Kong IPO influx
The biotech can boast a long list of big-name backers and has brought a promising drug to the market with its partner Innovent, but its cash reserves are dwindling Key…